Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

It is time to reassess mental disorders, recognizing that these are disorders of brain circuits likely caused by development processes, according to a commentary in the May 19 issue of JAMA, a theme issue on mental health.

19 May 2010

Majority of patients experience depression following hospitalization for TBI: Study

During the year following hospitalization for a traumatic brain injury, a majority of patients experienced major depression, according to a study in the May 19 issue of JAMA, a theme issue on mental health.

19 May 2010

Taking the final step from the bench to the hospital or clinic bedside

A new Regenstrief Institute and Indiana University Center for Aging Research (IUCAR) study provides effective strategies to help hospital systems, physicians and other care providers to overcome end zone hurdles and actually take evidence-based research to the patient’s hospital or clinic bedside.

18 May 2010

Taking the final step from the bench to the hospital or clinic bedside

18 May 2010

Repetitive treatment with cocktail of B vitamins improve recovery after TBI

Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.

18 May 2010

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Authors of the report, "Cellphones and Brain Tumors: 15 Reasons for Concern, Science, Spin and the Truth Behind Interphone" have released a technical analysis of the long-awaited Interphone Study published today in the International Journal of Epidemiology.

18 May 2010

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).

18 May 2010

Millions of Americans continue to risk losing their hearing each day, warns audiologist

May is Better Hearing Month, but millions of Americans are continuing to needlessly risk losing their hearing each day, warns audiologist Dr. Cindy Beyer. "Almost all hearing loss is due to the aging process or to noise, but only noise-induced hearing loss can be prevented," says Dr. Beyer, senior vice president of HearUSA, a nationwide provider of hearing care and hearing aids.

18 May 2010

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.

18 May 2010

New research shows link between mental health and creativity

New research shows a possible explanation for the link between mental health and creativity. By studying receptors in the brain, researchers at Karolinska Institutet have managed to show that the dopamine system in healthy, highly creative people is similar in some respects to that seen in people with schizophrenia.

18 May 2010

Study of link between cell phone use and brain tumours inconclusive

The world's biggest investigation on possible links between cell phone use and brain tumours is inconclusive, according to a Canadian scientist who collaborated on the Interphone International Study Group. Jack Siemiatycki, a professor at the University of Montreal and an epidemiologist at the University of Montreal Hospital Research Center, says restricted access to participants compromised the validity of results of the study to be published in the May 18 International Journal of Epidemiology.

18 May 2010

GATC Biotech to sequence samples from pediatric brain tumors for world's largest cancer research project

GATC Biotech to sequence samples from brain tumors in children for the world's largest cancer research project. The aim of the German PedBrainTumor Consortium within the ICGC is to develop innovative diagnostic methods and treatments in order to be able to provide children with therapies which have fewer side effects in future.

18 May 2010

Eisai calls on Alzheimer's patients and caregivers to nominate pharmacists for 2010 C.A.R.E. Pharmacy Award

Eisai Inc., in coordination with the Alzheimer's Association, calls on individuals with Alzheimer's disease and their caregivers across America to nominate local pharmacists for the 2010 C.A.R.E. Pharmacy Award. This award recognizes the vital role that pharmacists play in helping the estimated 5.3 million Americans living with Alzheimer's disease and their almost 11 million caregivers.

18 May 2010

Patients who receive H-SRT for recurrent brain cancer live longer: Researchers

Patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives, according to researchers at Thomas Jefferson University.

18 May 2010

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.

18 May 2010

Sleeping newborns are better learners: Study

Sleeping newborns are better learners than thought, says a University of Florida researcher about a study that is the first of its type. The study could lead to identifying those at risk for developmental disorders such as autism and dyslexia.

18 May 2010

Caffeine normalizes brain function and prevents cognitive decline

Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated. Substantial evidence from epidemiological studies and fundamental research in animal models suggests that caffeine may be protective against the cognitive decline seen in dementia and Alzheimer's disease (AD).

18 May 2010

High-fat ketogenic diet effective in treating infantile spasms

The high-fat ketogenic diet can dramatically reduce or completely eliminate debilitating seizures in most children with infantile spasms, whose seizures persist despite medication, according to a Johns Hopkins Children's Center study published online April 30 in the journal Epilepsia.

18 May 2010

Altered blood flow leads to falls in elderly people: Research

A new study shows that altered blood flow in the brain due to high blood pressure and other conditions may lead to falls in elderly people. The research will be published in the May 18, 2010, issue of Neurology, the medical journal of the American Academy of Neurology. Each year, unintentional falls in the United States account for more than 16,000 deaths and 1.8 million emergency room visits.

18 May 2010

No clear evidence of a mobile phone and brain cancer link

Use of mobile phones has been under scrutiny for a while now with many claiming a link between mobile phone use and brain cancer. The mild radioactive waves generated from mobile phones have so far been poorly understood. There are no known mechanisms by which mobile phone radiation could cause cancer. Unlike x-rays, mobile phone radiation is non-ionising, and is too weak to break apart DNA, which is necessary to induce other cancers. However scientists do agree that this radiation might speed up a growing brain tumor.

17 May 2010

Brain News and Research

Further Reading

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

Majority of patients experience depression following hospitalization for TBI: Study

Taking the final step from the bench to the hospital or clinic bedside

Taking the final step from the bench to the hospital or clinic bedside

Repetitive treatment with cocktail of B vitamins improve recovery after TBI

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Millions of Americans continue to risk losing their hearing each day, warns audiologist

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

New research shows link between mental health and creativity

Study of link between cell phone use and brain tumours inconclusive

GATC Biotech to sequence samples from pediatric brain tumors for world's largest cancer research project

Eisai calls on Alzheimer's patients and caregivers to nominate pharmacists for 2010 C.A.R.E. Pharmacy Award

Patients who receive H-SRT for recurrent brain cancer live longer: Researchers

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sleeping newborns are better learners: Study

Caffeine normalizes brain function and prevents cognitive decline

High-fat ketogenic diet effective in treating infantile spasms

Altered blood flow leads to falls in elderly people: Research

No clear evidence of a mobile phone and brain cancer link

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News